TEVA

Teva Pharmaceutical Industries Limited
$44.25+$0.60+1.36%Price as of Nov 13, 2026, 7:42 PM ET

Key stats

Market cap
51.6B
Open
—
Day range
—
52-week range
$24.01 – $44.57
Volume
6.17M
Avg volume
7.00M

Earnings

Q3 FY26
Actual$0.20
Q2 FY26
Actual$-0.49
Q1 FY26
Actual$0.31
Q4 FY25
Actual$0.41

Next earnings call Jan 27, 2027

About

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Employees
32,842
Headquarters
Tel Aviv,